| abstract |
The invention relates to the use of a tryptophanyl ester or an N-acyl derivative of a tryptophanyl ester for the prophylaxis and treatment of oxidative pathological processes in degenerative diseases and/or carcinomas. The tryptophanyl ester or its N-acyl derivative are preferably tryptophanoctyl ester, N-oleol-tryptophan ethyl ester or N-dodecanoyl-tryptophan ethyl ester. Furthermore, the tryptophanyl esters and their N-acyl derivatives are preferably used for the treatment and/or prophylaxis of neurodegenerative diseases, cataracts, neoplastic diseases and/or cardiovascular diseases. The invention notably relates to the use of the tryptophanyl esters and their N-acyl derivatives for the treatment and/or prevention of Alzheimer's disease, Parkinson disease, stroke, amyotrophic lateral sclerosis, cancer, arteriosclerosis and/or myocardial infarction. The invention further relates to a medicament containing a tryptophanyl ester or an N-acyl derivative of a tryptophanyl ester. |